Skip to content

A study to assess the influence of the nutritional supplement VERISOL® B (collagen peptides) on several biophysical parameters

A study to assess the influence of the nutritional supplement VERISOL® B (collagen peptides) on several biophysical parameters

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036187
Enrollment
60
Registered
2025-02-17
Start date
2018-10-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin health in the context of natural skin agin

Interventions

Group 1: Intervention Group: Specific Bioactive Collagen Peptides (SCP) – VERISOL® B Description: Participants in the intervention group receive a daily dose of 2.5 g of specific bovine-derived bioac

Sponsors

Collagen Research Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 55 Years

Inclusion criteria

Inclusion criteria: -Fitzpatrick skin type I to IV -Generally in good health and mental condition -Personal informed consent to participate in the study -Personal presence at the institute on the specified days -Willingness and ability to comply with the study rules and a fixed schedule

Exclusion criteria

Exclusion criteria: -Deviation from the above inclusion criteria -Acute skin diseases (e.g., atopic eczema, atopic dermatitis, psoriasis) -Food allergies related to the supplemented products -Gastrointestinal disease or digestive disorders -Topical medication on the test sites within 6 weeks prior to study entry -Systemic medication with anti-inflammatory agents or antibiotics within 2 weeks prior to study entry -Systemic medication with corticosteroids and/or antihistamines within 4 weeks prior to study entry -Other systemic medication within 4 weeks prior to study entry -Systemic disease of the subject at study entry -Pregnancy or lactation -Immunological diseases -Severe diseases within 6 months prior to study entry -Severe diabetes -Alcohol and drug abuse -Participation in other studies with cosmetic products within 2 weeks before study entry or during the study -Participation in a study with a pharmaceutical preparation within 4 weeks before study entry -Intake of dietary supplements within 4 weeks before study entry and during the study, except for test products -Change in lifestyle or dietary habits during the study -Treatment with leave-on products or oily or moisturizing skin cleansing products on the test areas or change in usual skin care routine -Intense sun or artificial UV exposure (solarium) on the test areas within 1 week before study entry or during the study -Swimming, sauna, or intense sports within 1 day before measurements -Lack of compliance -Intellectual or mental inability to follow the study instructions

Design outcomes

Primary

MeasureTime frame
Change in eye wrinkle volume after 8 weeks of treatment

Secondary

MeasureTime frame
Change in skin elasticity after 4 and 8 weeks Change in skin hydration after 4 and 8 weeks

Countries

Germany

Contacts

Public ContactDörte Segger

SGS SIT GmbH

de.sit@sgs.com+ 49 403 553 810

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026